Clinical Trials

Study Title:
Pivotal, Randomized, Open-Label Study of OptuneĀ® (Tumor Treating Fields, 200kHz) Concomitant With Radiation Therapy and Temozolomide for the Treatment of Newly Diagnosed Glioblastoma

For more information about the trial above please contact the study team:

Principal Investigator, Scott Lindhorst, at lindhors@musc.edu.

Study Coordinator, Kristina Godwin, at woodrufk@musc.edu.

Trial opened at the following institutions: Medical University of South Carolina